The goal of this study is to evaluate the imaging capabilities of a new prostate-targeted PET system (P-PET) and determine whether it could be useful in detecting prostate cancer by comparing SOC whole body PET imaging. This pilot study will include adult men who have been diagnosed with or are suspected to have prostate cancer. Participants will undergo a standard-of-care PET/CT scan followed by an additional P-PET scan designed to provide detailed images of the prostate. The images from the two scans to assess how well the P-PET system can detect prostate cancer.
Qualitative comparison of PET scans acquired by the P-PET vs. WB PET
Unable to comply with the length of scan time due to the study imaging.
Single group
Prostate-Targeted PET- Scan (P-PET).
Diagnostic testParticipants will undergo a prostate-targeted PET scan to detect prostate cancer. This research scan is performed after the standard-of-care PET scan to evaluate its imaging capability. While the radioisotope is still active.
Qualitative comparison of PET scans acquired by the P-PET vs. WB PET
The primary outcome is the detection of prostate cancer lesions by the research prostate-targeted P-PET scan. Images from the P-PET scan will be compared to standard-of-care PET scan images to evaluate the sensitivity and clarity of the new imaging system in identifying cancerous lesions in the prostate.
Number of Prostate Lesions Detected by P-PET Compared with Standard-of-care Whole-Body PET
The number of pelvic lesions detected by P-PET in comparison with the number of lesions detected by standard-of-care whole body PET/CT.
Click on the lead sponsor to view all of their trials.
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Lead sponsor
Lawson Research Institute of St. Joseph's
Collaborator
This trial is not recruiting at the moment. You can still explore other options:
